Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: PLoS ONE 8(4): e62295. doi:10.1371/journal.pone.0062295
- Klassifikation
-
Biowissenschaften, Biologie
- Schlagwort
-
Bewegungsapparat
Haut
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2016
- Urheber
-
Dinther, Maarten van
Zhang, Juan
Weidauer, Stella E.
Boschert, Verena
Muth, Eva-Maria
Knappik, Achim
Gorter, David J. J. de
van Kasteren, Puck B.
Frisch, Christian
Müller, Thomas
Dijke, Peter ten
- URN
-
urn:nbn:de:bvb:20-opus-130981
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek.
Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dinther, Maarten van
- Zhang, Juan
- Weidauer, Stella E.
- Boschert, Verena
- Muth, Eva-Maria
- Knappik, Achim
- Gorter, David J. J. de
- van Kasteren, Puck B.
- Frisch, Christian
- Müller, Thomas
- Dijke, Peter ten
- Universität Würzburg
Entstanden
- 2016
Ähnliche Objekte (12)
Sclerostin and Cardiovascular Disease
The role of Wnt inhibitor sclerostin in rheumatoid arthritis
How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
The sclerostin-neutralizing antibody AbD09097 recognizes an epitope adjacent to sclerostin's binding site for the Wnt co-receptor LRP6
Copeptin und Sclerostin in schwangerschaftsassoziierten Erkrankungen
Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Sclerostin Inhibition in the Management of Osteoporosis
Serum sclerostin levels in osteoporotic fracture patients
The protective effect of the Wnt inhibitor sclerostin in inflammatory bone destruction
IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages
Strukturelle und funktionelle Charakterisierung des Knochenwachstums-Modulators Sclerostin
Sclerostin and Cardiovascular Disease
The role of Wnt inhibitor sclerostin in rheumatoid arthritis
How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
The sclerostin-neutralizing antibody AbD09097 recognizes an epitope adjacent to sclerostin's binding site for the Wnt co-receptor LRP6
Copeptin und Sclerostin in schwangerschaftsassoziierten Erkrankungen
Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Sclerostin Inhibition in the Management of Osteoporosis
Serum sclerostin levels in osteoporotic fracture patients
The protective effect of the Wnt inhibitor sclerostin in inflammatory bone destruction
IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages
Strukturelle und funktionelle Charakterisierung des Knochenwachstums-Modulators Sclerostin
Sclerostin and Cardiovascular Disease
The role of Wnt inhibitor sclerostin in rheumatoid arthritis
How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
The sclerostin-neutralizing antibody AbD09097 recognizes an epitope adjacent to sclerostin's binding site for the Wnt co-receptor LRP6
Copeptin und Sclerostin in schwangerschaftsassoziierten Erkrankungen
Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Sclerostin Inhibition in the Management of Osteoporosis
Serum sclerostin levels in osteoporotic fracture patients
The protective effect of the Wnt inhibitor sclerostin in inflammatory bone destruction
IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages